{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:02:58Z","timestamp":1790913778672,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Xiaohe Sci-Tech Talents Special Funding under Hunan Provincial Sci-Tech Talents Sponsorship Program","award":["No.2023TJ-X07"],"award-info":[{"award-number":["No.2023TJ-X07"]}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No.2024JJ5542"],"award-info":[{"award-number":["No.2024JJ5542"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese National key research and development program","award":["No.2022YFC2504700"],"award-info":[{"award-number":["No.2022YFC2504700"]}]},{"name":"Chinese Natural Science Foundation of China","award":["No.81872219"],"award-info":[{"award-number":["No.81872219"]}]},{"name":"Hunan Province Major Research Initiative for High-Level Health and Medical Talents","award":["No.R2023045"],"award-info":[{"award-number":["No.R2023045"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Circular RNAs (circRNAs) contribute to gene expression regulation by interacting with splicing factors, a process that is often disrupted in cancers such as cutaneous melanoma (CM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A circRNA microarray analysis was performed to identify differentially expressed circRNAs. qRT\u2012PCR was conducted to confirm the expression of circROR1. CCK-8, colony formation, wound healing, and transwell assays were used to analyze proliferation, metastasis and apoptosis in CM cells. Xenograft models and IHC experiments were established to confirm the effects of circROR1 on tumor growth and metastasis in vivo. RNA sequencing and pull-down\u2013MS experiments were performed to identify the mechanisms downstream of circROR1. Nuclear and cytoplasmic fractionation, along with FISH experiments, were conducted to determine the cellular localization of circROR1. To target circROR1 for CM treatment, we used a microfluidic strategy to develop FA-PEG(si-circ) nanoparticles for efficient siRNA delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In CM samples, circROR1 levels were positively correlated with HNRNPL levels and tumor metastasis but negatively correlated with FOXO4 protein levels. CircROR1 was prevalent in CM, and its upregulation increased the levels of factors involved in epithelial\u2013mesenchymal transition, cell migration, and invasion. CircROR1 overexpression conferred resistance to PD-L1-antibody therapy in CM cells by downregulating PD-L1 expression. CircROR1 recruited HNRNPL, influencing its nuclear translocation, and further prevented intron retention in FOXO4 mRNA. In HNRNPL-overexpressing CM cells, circROR1 upregulation inhibited FOXO4\u03b1 expression and promoted FOXO4\u03b6 expression. Increased FOXO4\u03b1 expression counteracted circROR1\u2019s effects and suppressed metastatic behaviors. FA-PEG(si-circ) enhanced siRNA stability and efficiency, reducing CM cell lung colonization in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified circROR1 as an oncogenic circular RNA that plays a crucial role in tumor progression and metastasis. CircROR1-targeted nanotherapy is a promising option for the treatment of metastatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12943-025-02525-1","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T10:35:51Z","timestamp":1768300551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CircROR1 binds HNRNPL to regulate FOXO4 pre-mRNA splicing, promoting cutaneous melanoma metastasis and serving as a therapeutic target via RNAi-loaded PEG-LNPs"],"prefix":"10.1186","volume":"25","author":[{"given":"Ke","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"2525_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158(5)","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158:495\u2013503. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0160.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"2525_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40257-017-0325-6","volume":"19","author":"EA Rozeman","year":"2018","unstructured":"Rozeman EA, Dekker TJA, Haanen JBAG, Blank CU. Advanced melanoma: current treatment options, biomarkers, and future perspectives. Am J Clin Dermatol. 2018;19(3):303-317. https:\/\/doi.org\/10.1007\/s40257-017-0325-6.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"2525_CR3","doi-asserted-by":"publisher","DOI":"10.1063\/1.5143779","volume":"4","author":"JP Baskaran","year":"2020","unstructured":"Baskaran JP, Weldy A, Guarin J, Munoz G, Oudin MJ. Cell shape, and not 2D migration, predicts extracellular matrix-driven 3D cell invasion in breast cancer. APL Bioeng. 2020;4(2):026105. https:\/\/doi.org\/10.1063\/1.5143779.","journal-title":"APL Bioeng"},{"key":"2525_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40265-018-0884-8","volume":"78","author":"JN Sanchez","year":"2018","unstructured":"Sanchez JN, Wang T, Cohen MS. BRAF and MEK inhibitors: use and resistance in BRAF-mutated cancers. Drugs. 2018;78:549\u2013566. https:\/\/doi.org\/10.1007\/s40265-018-0884-8.","journal-title":"Drugs"},{"key":"2525_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000705","volume":"8","author":"S Hu-Lieskovan","year":"2020","unstructured":"Hu-Lieskovan S, Bhaumik S, Dhodapkar K, Grivel JCJB, Maecker HT. SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery. J Immunother Cancer. 2020;8:e000705. https:\/\/doi.org\/10.1136\/jitc-2020-000705.","journal-title":"J Immunother Cancer"},{"key":"2525_CR6","doi-asserted-by":"publisher","unstructured":"Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16:94. https:\/\/doi.org\/10.1186\/s12943-017-0663-2.","DOI":"10.1186\/s12943-017-0663-2"},{"key":"2525_CR7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.7150\/ijbs.55381","volume":"17","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jia D, Zhang Y, Cheng M, Zhu W, Li P, et al. The emerging function and clinical significance of circRNAs in thyroid cancer and autoimmune thyroid diseases. Int J Biol Sci. 2021;17:1731\u2013 1741. https:\/\/doi.org\/10.7150\/ijbs.55381.","journal-title":"Int J Biol Sci"},{"key":"2525_CR8","doi-asserted-by":"publisher","unstructured":"Chen C, Weitang Y, Quanbo Z, Bo S, Yuying G, Weiwei W, Shuaixi Y, Yaxin G, Luyang Z, Qin D, et al. N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization. Theranostics. 202111:4298-4315. https:\/\/doi.org\/10.7150\/thno.51342.","DOI":"10.7150\/thno.51342"},{"key":"2525_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05562-4","volume":"22","author":"J Zhang","year":"2024","unstructured":"Zhang J, Luo Z, Zheng Y, Duan M, Qiu Z, Huang C. Circrna as an Achilles heel of cancer: characterization, biomarker and therapeutic modalities. J Transl Med. 2024;22:752. https:\/\/doi.org\/10.1186\/s12967-024-05562-4.","journal-title":"J Transl Med"},{"key":"2525_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0914-x","volume":"17","author":"K Zeng","year":"2018","unstructured":"Zeng K, He B, Yang BB, Xu T, Chen X, Xu M, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018;17:160. https:\/\/doi.org\/10.1186\/s12943-018-0914-x.","journal-title":"Mol Cancer"},{"key":"2525_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111243","author":"J Li","year":"2024","unstructured":"Li J, Qian L, Ge M, Zhao J, Yang Y. hsa_circ_0000518 stimulates the malignant progression of hepatocellular carcinoma via regulating ITGA5 to activate the Warburg effect. Cell Signal. 2024;120:111243 . https:\/\/doi.org\/10.1016\/j.cellsig.2024.111243.","journal-title":"Cell Signal"},{"key":"2525_CR12","doi-asserted-by":"publisher","unstructured":"Chu S, Fei B, Yu M.Molecular mechanism of circ_0088300\u2013BOLL interaction regulating mitochondrial metabolic reprogramming and involved in gastric cancer growth and metastasis. J Proteome Res.\u00a02023;22:3793-3810. https:\/\/doi.org\/10.1021\/acs.jproteome.3c00476.","DOI":"10.1021\/acs.jproteome.3c00476"},{"key":"2525_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.32604\/or.2024.045972","volume":"32","author":"A Zhao","year":"2024","unstructured":"Zhao A, Wang Y, Wang Z, Shao Q, Gong QI, Zhu H, et al. Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of epidermal growth factor receptor. Oncol Res. 2024;32:983\u201398. https:\/\/doi.org\/10.32604\/or.2024.045972.","journal-title":"Oncol Res"},{"key":"2525_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301107","volume":"10","author":"W Sun","year":"2023","unstructured":"Sun W, Ji P, Zhou T, Li Z, Xing C, Zhang L, et al. Ultrasound responsive nanovaccine armed with engineered cancer cell membrane and RNA to prevent foreseeable metastasis. Adv Sci. 2023;10:e2301107. https:\/\/doi.org\/10.1002\/advs.202301107.","journal-title":"Adv Sci"},{"key":"2525_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.04.040","author":"J Gu","year":"2020","unstructured":"Gu J, Chen Z, Chen X, Wang Z. Heterogeneous nuclear ribonucleoprotein (hnRNPL) in cancer. Clin Chim Acta. 2020;507:286-294. https:\/\/doi.org\/10.1016\/j.cca.2020.04.040.","journal-title":"Clin Chim Acta"},{"key":"2525_CR16","doi-asserted-by":"publisher","unstructured":"ColeCole BS, Tapescu I, Allon SJ, Mallory MJ, Qiu J, Lake RJ, et al. Global analysis of physical and functional RNA targets of hnRNP L reveals distinct sequence and epigenetic features of repressed and enhanced exons. RNA.2015;21:2053-2066. https:\/\/doi.org\/10.1261\/rna.052969.115.","DOI":"10.1261\/rna.052969.115"},{"key":"2525_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202154157","volume":"23","author":"Y Fouani","year":"2022","unstructured":"Fouani Y, Kirchhof L, Stanicek L, Guillermo.Lux\u00e1n W, Heum\u00fcller A, Knau A, et al. The splicing-regulatory lncRNA NTRAS sustains vascular integrity. EMBO Rep. 2022;23:e54157. https:\/\/doi.org\/10.15252\/embr.202154157.","journal-title":"EMBO Rep"},{"key":"2525_CR18","doi-asserted-by":"publisher","unstructured":"Liu G, Razanau A, Hai Y, Yu J, Sohail M, Lobo VG, et al.A conserved serine of heterogeneous nuclear ribonucleoprotein L (hnRNP L) mediates depolarization-regulated alternative splicing of potassium channels. J Biol Chem. 2012;287(27):22709-16. hhttps:\/\/doi.org\/10.1074\/jbc.M112.357343.","DOI":"10.1074\/jbc.M112.357343"},{"key":"2525_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-024-06561-5","volume":"12","author":"X Tan","year":"2021","unstructured":"Tan X, Chen WB. Lv DJ , Yang T, Wu K, Zou LB, et al.LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer. Cell Death Dis. 2021;12:138. https:\/\/doi.org\/10.1038\/s41419-024-06561-5.","journal-title":"Cell death & disease"},{"key":"2525_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568469","volume":"10","author":"C Mei","year":"2020","unstructured":"Mei C, Song P, Zhang W, Zhou H, Li X, Liu Z. Aberrant RNA splicing events driven by mutations of RNA-binding proteins as indicators for skin cutaneous melanoma prognosis. Front Oncol. 2020;10:568469. https:\/\/doi.org\/10.3389\/fonc.2020.568469.","journal-title":"Front Oncol"},{"key":"2525_CR21","doi-asserted-by":"publisher","unstructured":"Qi W, Jia C, Aijun W, Lichun S, Li Q, Xiao Z, et al. Differentially expressed circRNAs in melanocytes and melanoma cells and their effect on cell proliferation and invasion. Oncol Rep. 2018;39:1813-1824. https:\/\/doi.org\/10.3892\/or.2018.6263.","DOI":"10.3892\/or.2018.6263"},{"key":"2525_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15071","volume":"33","author":"L Sun","year":"2024","unstructured":"Sun L, Bin S, Huang C, Wang Q. CircROR1 upregulates CCNE1 expression to promote melanoma invasion and metastasis by recruiting KAT2A. Exp Dermatol. 2024;33:e15071. https:\/\/doi.org\/10.1111\/exd.15071.","journal-title":"Exp Dermatol"},{"key":"2525_CR23","doi-asserted-by":"publisher","unstructured":"Zhu X, Zhang P. m6A-modified circXPO1 accelerates colorectal cancer progression via interaction with FMRP to promote WWC2 mRNA decay. J Transl Med. 2024;22:931. https:\/\/doi.org\/10.1186\/s12967-024-05716-4.","DOI":"10.1186\/s12967-024-05716-4"},{"key":"2525_CR24","doi-asserted-by":"publisher","unstructured":"Zheng L, Liang H, Zhang Q, Shen Z, Sun Y, Zhao X, et al. circPTEN1, a circular RNA generated from PTEN, suppresses cancer progression through inhibition of TGF-\u03b2\/Smad signaling. Mol Cancer. 2022;21:41. https:\/\/doi.org\/10.1186\/s12943-022-01495-y.","DOI":"10.1186\/s12943-022-01495-y"},{"key":"2525_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41586-021-03520-4","volume":"595","author":"GK Griffin","year":"2021","unstructured":"Griffin GK, Wu J, Iracheta-Vellve A. Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity. Nature. 2021;595:309\u201314. https:\/\/doi.org\/10.1038\/s41586-021-03520-4.","journal-title":"Nature"},{"key":"2525_CR26","doi-asserted-by":"publisher","unstructured":"Zhou X, Liu Y, Hu M. Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy. Sci Adv. 2021;7:eabb6596. https:\/\/doi.org\/10.1126\/sciadv.abb6596.","DOI":"10.1126\/sciadv.abb6596"},{"key":"2525_CR27","doi-asserted-by":"publisher","unstructured":"Mu H, Chen J, Huang W, Huang G, Deng M, Hong S, et al. OmicShare tools: A zero-code interactive online platform for biological data analysis and visualization. iMeta;3:e228. https:\/\/doi.org\/10.1002\/imt2.228.","DOI":"10.1002\/imt2.228"},{"key":"2525_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","journal-title":"Nat Commun"},{"key":"2525_CR29","doi-asserted-by":"publisher","unstructured":"Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, et al. Integrative genome comparison of primary and metastatic melanomas. PLoS One. 2010;5:e10770. https:\/\/doi.org\/10.1371\/journal.pone.0010770.","DOI":"10.1371\/journal.pone.0010770"},{"key":"2525_CR30","doi-asserted-by":"publisher","unstructured":"Jalili A, Mertz KD, Romanov J, Wagner C, Kalthoff F, Stuetz A, et al. NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo. PLoS One. 2013;8:e69064. https:\/\/doi.org\/10.1371\/journal.pone.0069064.","DOI":"10.1371\/journal.pone.0069064"},{"key":"2525_CR31","doi-asserted-by":"publisher","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98-W102. https:\/\/doi.org\/10.1093\/nar\/gkx247.","DOI":"10.1093\/nar\/gkx247"},{"key":"2525_CR32","doi-asserted-by":"publisher","unstructured":"Paz I, Kosti I, Ares M Jr, Cline M, Mandel-Gutfreund Y. RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res. 2014;42:W361-W367. https:\/\/doi.org\/10.1093\/nar\/gku406.","DOI":"10.1093\/nar\/gku406"},{"key":"2525_CR33","doi-asserted-by":"publisher","unstructured":"Shan H, Sun X, Liu X, Sun Q, He Y, Chen Z, et al. One-Step Formation of Targeted Liposomes in a Versatile Microfluidic Mixing Device. Small. 2022;19:e2205498. https:\/\/doi.org\/10.1002\/smll.202205498.","DOI":"10.1002\/smll.202205498"},{"key":"2525_CR34","doi-asserted-by":"publisher","unstructured":"Du A, Li S, Zhou Y, Disoma C, Liao Y, Zhang Y, et al. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer. 2022;21:109. https:\/\/doi.org\/10.1186\/s12943-022-01575-z.","DOI":"10.1186\/s12943-022-01575-z"},{"key":"2525_CR35","doi-asserted-by":"publisher","unstructured":"Yang Z, Whelan J, Babb R, Bowen BR. An mRNA splice variant of the AFX gene with altered transcriptional activity. J Biol Chem. 2002;277:8068-8075. https:\/\/doi.org\/10.1074\/jbc.m106091200.","DOI":"10.1074\/jbc.m106091200"},{"key":"2525_CR36","doi-asserted-by":"publisher","unstructured":"Sun Z, Xu Y, Si C, Wu X, Guo Y, Chen C, et al. Targeting m7G-enriched circKDM1A prevents colorectal cancer progression. Mol Cancer;23:179. https:\/\/doi.org\/10.1186\/s12943-024-02090-z.","DOI":"10.1186\/s12943-024-02090-z"},{"key":"2525_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736-18-31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, et al. Melanoma. Lancet. 2018;392:971\u201384. https:\/\/doi.org\/10.1016\/S0140-6736-18-31559-9.","journal-title":"Lancet"},{"key":"2525_CR38","doi-asserted-by":"publisher","unstructured":"Gla\u017ear P, Papavasileiou P, Rajewsky N. circBase: a database for circular RNAs. RNA. 2014;20:1666-1670. https:\/\/doi.org\/10.1261\/rna.043687.113.","DOI":"10.1261\/rna.043687.113"},{"key":"2525_CR39","doi-asserted-by":"publisher","unstructured":"Zhong S, Feng J. CircPrimer 2.0: a software for annotating circRNAs and predicting translation potential of circRNAs. BMC Bioinformatics 2022;23:215. https:\/\/doi.org\/10.1186\/s12859-022-04705-y.","DOI":"10.1186\/s12859-022-04705-y"},{"key":"2525_CR40","doi-asserted-by":"publisher","unstructured":"Murta D, Maxia C, Diana A, Pilloni L, Corda C, Minerba L, et al. Role of epithelial\u2013mesenchymal transition involved molecules in the progression of cutaneous melanoma. Histochem Cell Biol. 2017;148:639-649. https:\/\/doi.org\/10.1007\/s00418-017-1606-0.","DOI":"10.1007\/s00418-017-1606-0"},{"key":"2525_CR41","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560:382\u2013386. https:\/\/doi.org\/10.1038\/s41586-018-0392-8.","journal-title":"Nature"},{"key":"2525_CR42","doi-asserted-by":"publisher","unstructured":"Pi\u00f1ol-Roma S, Swanson MS, Gall JG, Dreyfuss G. A novel heterogeneous nuclear RNP Protein with a unique distribution on nascent transcripts.\u00a0J Cell Biol. 1989;109:2575-2587. https:\/\/doi.org\/10.1083\/jcb.109.6.2575.","DOI":"10.1083\/jcb.109.6.2575"},{"key":"2525_CR43","doi-asserted-by":"publisher","unstructured":"Loh TJ, Cho S, Moon H, Jang HN, Williams DR, Jung DW, et al. hnRNP L inhibits CD44 V10 exon splicing through interacting with its upstream intron. Biochim Biophys Acta. 2015;1849:743-750. https:\/\/doi.org\/10.1016\/j.bbagrm.2015.01.004.","DOI":"10.1016\/j.bbagrm.2015.01.004"},{"key":"2525_CR44","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.7150\/thno.21299","volume":"7","author":"WW Du","year":"2017","unstructured":"Du WW, Zhang C, Yang W, Yong T, Awan FM, Yang BB. Identifying and characterizing circRNA-protein interaction. Theranostics. 2017;7:4183\u20134191. https:\/\/doi.org\/10.7150\/thno.21299.","journal-title":"Theranostics"},{"key":"2525_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"WY Zhou","year":"2020","unstructured":"Zhou WY, Cai ZR, Liu J, Wang DS, Ju HQ, Xu RH. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19:172. https:\/\/doi.org\/10.1186\/s12943-020-01286-3.","journal-title":"Mol Cancer"},{"key":"2525_CR46","doi-asserted-by":"publisher","unstructured":"Qi J, Cui D, Wu QN, Zhao Q, Chen ZH, Li L, et al. Targeting Wnt\/\u03b2-Catenin signaling by TET1\/FOXO4 inhibits metastatic spreading and self-renewal of cancer stem cells in gastric cancer. Cancers (Basel). 2022;14:3232. https:\/\/doi.org\/10.3390\/cancers14133232.","DOI":"10.3390\/cancers14133232"},{"key":"2525_CR47","doi-asserted-by":"publisher","unstructured":"Zhao C, Zhang J, Yang ZY, Shi LQ, Liu SL, Pan LJ, et al. Ponicidin inhibited gallbladder cancer proliferation and metastasis by decreasing MAGEB2 expression through FOXO4. Phytomedicine. 2023;114:154785. https:\/\/doi.org\/10.1016\/j.phymed.2023.154785.","DOI":"10.1016\/j.phymed.2023.154785"},{"key":"2525_CR48","doi-asserted-by":"publisher","unstructured":"Peters U, Haberhausen G, Kostrzewa M, Nolte D, M\u00fcller U. AFX1 and p54nrb: fine mapping, genomic structure, and exclusion as candidate genes of X-linked dystonia parkinsonism. Hum Genet. 1997;100:569-572. https:\/\/doi.org\/10.1007\/s004390050553.","DOI":"10.1007\/s004390050553"},{"key":"2525_CR49","doi-asserted-by":"publisher","unstructured":"Wei PS, Thota N, John G, Chang E, Lee S, Wang Y, et al. Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies. J Control Release. 2024;375:366-388. https:\/\/doi.org\/10.1016\/j.jconrel.2024.08.030.","DOI":"10.1016\/j.jconrel.2024.08.030"},{"key":"2525_CR50","doi-asserted-by":"publisher","unstructured":"Beraza-Millor M, Rodr\u00edguez-Castej\u00f3n J, Del Pozo-Rodr\u00edguez A, Rodr\u00edguez-Gasc\u00f3n A, Solin\u00eds M\u00c1. Systematic review of genetic substrate reduction therapy in lysosomal storage diseases: opportunities, challenges and delivery systems. BioDrugs. 2024;38:657-680. https:\/\/doi.org\/10.1007\/s40259-024-00674-1.","DOI":"10.1007\/s40259-024-00674-1"},{"key":"2525_CR51","doi-asserted-by":"publisher","unstructured":"Scaranti M, Cojocaru E, Banerjee S, Banerji U. Exploiting the folate receptor \u03b1 in oncology. Nat Rev Clin Onco. 2020;17:349-359. https:\/\/doi.org\/10.1038\/s41571-020-0339-5.","DOI":"10.1038\/s41571-020-0339-5"},{"key":"2525_CR52","doi-asserted-by":"publisher","unstructured":"Farran B, Pavitra E, Kasa P, Peela S, Rama Raju GS, Nagaraju GP. Folate-targeted immunotherapies: Passive and active strategies for cancer. Cytokine Growth Factor Rev. 2019;45:45-52. https:\/\/doi.org\/10.1016\/j.cytogfr.2019.02.001.","DOI":"10.1016\/j.cytogfr.2019.02.001"},{"key":"2525_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol. 2018;13:395\u2013412. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043854.","journal-title":"Annu Rev Pathol"},{"key":"2525_CR54","doi-asserted-by":"publisher","unstructured":"Yin GH, Gao FC, Tian J, Zhang WB. Hsa_circ_101882 promotes migration and invasion of gastric cancer cells by regulating EMT. J Clin Lab Anal. 2019;33:e23002. https:\/\/doi.org\/10.1002\/jcla.23002.","DOI":"10.1002\/jcla.23002"},{"key":"2525_CR55","doi-asserted-by":"publisher","unstructured":"Wang C, Tang D, Wang H, Hu G, Hu S, Li L, et al. Circular RNA hsa_circ_0030018 acts as a sponge of miR-599 to aggravate esophageal carcinoma progression by regulating ENAH expression. J Cell Biochem. 2019;121:3730-3738. https:\/\/doi.org\/10.1002\/jcb.29507.","DOI":"10.1002\/jcb.29507"},{"key":"2525_CR56","doi-asserted-by":"publisher","unstructured":"Wang R, Zhang S, Chen X, Li N, Li J, Jia R, et al. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis. Mol Cancer. 2018;17:166. https:\/\/doi.org\/10.1186\/s12943-018-0911-0.","DOI":"10.1186\/s12943-018-0911-0"},{"key":"2525_CR57","doi-asserted-by":"publisher","unstructured":"Ji J, Li C, Wang J, Wang L, Huang H, Li Y, et al. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR\/MAPK signaling pathway. Cell Cycle. 2022;21:685-696. https:\/\/doi.org\/10.1080\/15384101.2021.2010166.","DOI":"10.1080\/15384101.2021.2010166"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02525-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02525-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:40:49Z","timestamp":1781628049000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02525-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2525"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02525-1","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"11 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed informed consent forms, and the protocols were approved by the Ethics Committee of Xiangya Hospital of Central South University (202308636) and Shanghai Zhuoli Biotechnology Company Ltd (LLSM-15-01). All experimental animals were reviewed and approved by the Ethics Committee of Central South University (XMSB-2023-0013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of manuscript in\n                      MOLECULAR CANCER\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}